Trial Profile
An open label, two-part, xed-sequence, crossover drug drug interaction study evaluating the effects of Itraconazole and Rifampin on the pharmacokinetics of HT3951 in healthy subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Apr 2018
Price :
$35
*
At a glance
- Drugs HT 3951 (Primary)
- Indications Stroke
- Focus Pharmacokinetics
- 02 Apr 2018 New trial record
- 24 Mar 2018 Results presented at the 119th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics